ASH HIGHLIGHTS 2023 – LEUKEMIA ROUNDTABLE DISCUSSION: ABL001 In Combination With Dasatinib And Prednisone For BCR-ABL1-Positive ALL And Blast Phase CML In Adults
don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"Best of Oncology Podcast Series","authorlink":""},"src":"https:\/\/traffic.libsyn.com\/secure\/bestofoncology\/ASH_2023_Leukemia_Roundtable_-_ABL001_in_Combination_with_Dasatinib_and_Prednisone_for_BCR-ABL1.mp3?dest-id=1101521","thumb":{"src":"https:\/\/lystnimg.b-cdn.net\/podcastsnw-202311\/090a51-8209-9524-b316f9_800.png"},"title":"ASH HIGHLIGHTS 2023 \u2013 LEUKEMIA ROUNDTABLE DISCUSSION: ABL001 In Combination With Dasatinib And Prednisone For BCR-ABL1-Positive ALL And Blast Phase CML In Adults","link":"javascript:;","id":"item-99594424"}]
